Notify me when Silver Lake Advisory, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 103 | $257,841,615 | +$9,041,741 | -$3,579,669 | +$5,462,072 | SGOV, ABBV, CSCO, BRKB, GLW | 13F-HR | 08 Jan 2026, 18:19 |
| Q3 2025 | 104 | $251,068,232 | +$12,667,749 | -$8,859,632 | +$3,808,117 | SGOV, ABBV, BRKB, CSCO, GLW | 13F-HR | 14 Oct 2025, 20:46 |
| Q2 2025 | 104 | $234,817,953 | +$5,446,308 | -$2,870,053 | +$2,576,255 | BRKB, CSCO, ABBV, VIGI, ABT | 13F-HR | 21 Jul 2025, 19:59 |
| Q1 2025 | 99 | $229,202,051 | +$10,502,251 | -$11,361,510 | -$859,259 | BRKB, ABBV, CSCO, PAYX, ABT | 13F-HR | 23 Apr 2025, 11:04 |
| Q4 2024 | 96 | $225,353,720 | +$2,096,328 | -$17,482,031 | -$15,385,703 | BRKB, ABBV, CSCO, PAYX, ABT | 13F-HR | 21 Jan 2025, 08:26 |
| Q3 2024 | 99 | $241,981,592 | +$8,043,007 | -$4,374,189 | +$3,668,818 | ABBV, BRKB, DLR, PID, PAYX | 13F-HR | 08 Nov 2024, 20:12 |
| Q2 2024 | 94 | $220,057,845 | +$7,308,504 | -$5,158,258 | +$2,150,246 | ABBV, BRKB, DLR, QCOM, PID | Restatement | 15 Aug 2024, 14:50 |
| Q1 2024 | 96 | $222,478,102 | +$38,364,785 | -$5,773,160 | +$32,591,625 | ABBV, BRKB, DLR, PID, PAYX | 13F-HR | 23 Apr 2024, 15:37 |
| Q4 2023 | 54 | $178,452,000 | +$7,154,651 | -$1,307,979 | +$5,846,672 | ABBV, DLR, BRKB, PID, PAYX | 13F-HR | 06 Feb 2024, 09:27 |
| Q3 2023 | 53 | $162,115,000 | +$8,212,478 | -$26,782,612 | -$18,570,134 | ABBV, BRKB, CSCO, DLR, PID | 13F-HR | 25 Oct 2023, 10:34 |
| Q2 2023 | 93 | $187,039,060 | +$8,994,281 | -$5,226,467 | +$3,767,814 | ABBV, BRKB, PID, CSCO, DLR | 13F-HR | 24 Jul 2023, 13:55 |
| Q1 2023 | 90 | $180,140,778 | +$27,027,984 | -$11,011,138 | +$16,016,846 | ABBV, PID, BRKB, CSCO, FSLR | 13F-HR | 25 Apr 2023, 09:16 |
| Q4 2022 | 57 | $164,081,109 | +$2,866,738 | -$24,587,518 | -$21,720,780 | ABBV, CSCO, BRKB, JNJ, PID | 13F-HR | 30 Jan 2023, 10:09 |
| Q3 2022 | 94 | $170,913,000 | +$1,458,539 | -$4,825,826 | -$3,367,287 | ABBV, CSCO, JNJ, BRKB, PAYX | 13F-HR | 20 Oct 2022, 09:41 |
| Q2 2022 | 97 | $183,281,000 | +$4,216,007 | -$7,858,083 | -$3,642,076 | ABBV, JNJ, CSCO, PID, BRKB | Restatement | 28 Jul 2022, 09:08 |
| Q1 2022 | 104 | $210,572,000 | +$5,014,527 | -$8,314,636 | -$3,300,109 | ABBV, CSCO, BRKB, PAYX, PID | 13F-HR | 02 May 2022, 12:14 |
| Q4 2021 | 108 | $216,083,000 | +$10,756,929 | -$14,217,652 | -$3,460,723 | ABBV, CSCO, PAYX, ABT, BRKB | 13F-HR | 13 Jan 2022, 13:17 |
| Q3 2021 | 106 | $203,038,000 | +$11,050,417 | -$9,219,330 | +$1,831,087 | ABBV, CSCO, PID, BRKB, JNJ | 13F-HR | 28 Oct 2021, 10:13 |
| Q2 2021 | 104 | $204,008,000 | +$5,709,591 | -$6,363,200 | -$653,609 | ABBV, CSCO, PAYX, JNJ, BRKB | 13F-HR | 04 Aug 2021, 10:33 |
| Q1 2021 | 99 | $196,464,000 | +$11,649,121 | -$13,426,512 | -$1,777,391 | ABBV, CSCO, PAYX, JNJ, ABT | 13F-HR | 27 Apr 2021, 09:42 |
| Q4 2020 | 93 | $182,654,000 | +$9,057,202 | -$9,271,005 | -$213,803 | ABBV, CSCO, ABT, PAYX, JNJ | Restatement | 04 Feb 2021, 09:23 |
| Q3 2020 | 88 | $162,517,000 | +$9,064,959 | -$5,754,921 | +$3,310,038 | ABBV, ABT, CSCO, INTC, JNJ | 13F-HR | 04 Nov 2020, 10:08 |
| Q2 2020 | 82 | $156,297,000 | +$6,357,049 | -$4,998,106 | +$1,358,943 | ABBV, CSCO, INTC, BDX, JNJ | 13F-HR | 28 Jul 2020, 13:16 |
| Q1 2020 | 81 | $136,128,000 | +$11,665,463 | -$4,415,574 | +$7,249,889 | CSCO, INTC, ABT, BDX, ABBV | Restatement | 22 Apr 2020, 12:11 |
| Q4 2019 | 80 | $165,751,000 | +$9,214,026 | -$5,708,597 | +$3,505,429 | BDX, ABBV, INTC, CSCO, ABT | 13F-HR | 14 Feb 2020, 08:59 |
| Q3 2019 | 79 | $154,823,000 | +$6,767,554 | -$5,357,955 | +$1,409,599 | CSCO, BDX, ABT, HAS, INTC | 13F-HR | 21 Oct 2019, 09:40 |
| Q2 2019 | 80 | $151,072,000 | +$4,654,150 | -$4,155,131 | +$499,019 | CSCO, ABT, BDX, INTC, JNJ | 13F-HR | 01 Aug 2019, 11:28 |
| Q1 2019 | 82 | $148,287,000 | +$9,360,651 | -$10,508,507 | -$1,147,856 | CSCO, ABT, BDX, INTC, JNJ | Restatement | 18 Apr 2019, 09:02 |
| Q4 2018 | 81 | $134,667,000 | +$2,135,841 | -$16,071,123 | -$13,935,282 | ABT, CSCO, BDX, INTC, JNJ | 13F-HR | 05 Feb 2019, 09:09 |
| Q3 2018 | 96 | $164,493,000 | +$43,860,883 | -$10,622,119 | +$33,238,764 | BDX, CSCO, ABT, JNJ, INTC | Restatement | 16 Oct 2018, 10:19 |
| Q2 2018 | 78 | $77,802,000 | +$10,296,714 | -$24,306,555 | -$14,009,841 | JNJ, BDX, IP, EMR, OMC | 13F-HR | 16 Jul 2018, 10:09 |
| Q1 2018 | 84 | $134,639,000 | +$5,381,855 | -$5,809,935 | -$428,080 | GWW, INTC, CSCO, BDX, ABT | 13F-HR | 17 Apr 2018, 11:58 |
| Q4 2017 | 86 | $140,360,000 | +$6,224,129 | -$1,705,651 | +$4,518,478 | INTC, BDX, JNJ, GWW, ABT | 13F-HR | 31 Jan 2018, 11:48 |
| Q3 2017 | 83 | $131,149,000 | +$9,557,808 | -$15,843,508 | -$6,285,700 | CVS, JNJ, BDX, ABT, IP | 13F-HR | 17 Oct 2017, 10:44 |
| Q2 2017 | 84 | $134,920,000 | +$2,679,797 | -$2,028,719 | +$651,078 | HAS, JNJ, CVS, BDX, IP | 13F-HR | 17 Jul 2017, 10:08 |
| Q1 2017 | 81 | $132,774,000 | +$3,796,693 | -$6,375,478 | -$2,578,785 | CVS, GE, JNJ, BDX, HAS | 13F-HR | 16 May 2017, 14:42 |
| Q4 2016 | 80 | $129,428,000 | +$2,765,202 | -$7,246,404 | -$4,481,202 | GE, CVS, JNJ, IP, BDX | 13F-HR | 30 Jan 2017, 12:08 |
| Q3 2016 | 79 | $134,170,000 | +$2,603,541 | -$3,310,975 | -$707,434 | T, BDX, CVS, GE, JNJ | 13F-HR | 11 Oct 2016, 09:49 |
| Q2 2016 | 78 | $134,180,000 | +$14,438,375 | -$3,217,526 | +$11,220,849 | T, CVS, GE, BDX, JNJ | 13F-HR | 13 Jul 2016, 12:04 |
| Q1 2016 | 65 | $117,445,000 | +$7,683,201 | -$7,670,013 | +$13,188 | T, CVS, GE, BDX, JNJ | 13F-HR | 20 Apr 2016, 12:10 |
| Q4 2015 | 68 | $111,884,000 | +$3,764,630 | -$8,483,672 | -$4,719,042 | CVS, BMY, T, GE, BDX | 13F-HR | 19 Jan 2016, 14:49 |
| Q3 2015 | 70 | $111,051,000 | +$7,732,666 | -$9,834,098 | -$2,101,432 | CVS, T, BMY, GE, BDX | 13F-HR | 13 Oct 2015, 11:29 |
| Q2 2015 | 77 | $123,191,000 | +$8,417,622 | -$7,280,627 | +$1,136,995 | CVS, BMY, T, IP, BDX | 13F-HR | 15 Jul 2015, 10:43 |
| Q1 2015 | 73 | $124,162,000 | +$7,984,299 | -$5,041,647 | +$2,942,652 | CVS, BMY, IP, T, BDX | 13F-HR | 15 Apr 2015, 11:56 |
| Q4 2014 | 76 | $123,078,000 | +$6,138,450 | -$7,506,363 | -$1,367,913 | CVS, ABBV, BMY, T, IP | 13F-HR | 20 Jan 2015, 14:47 |
| Q3 2014 | 77 | $122,024,000 | +$6,903,707 | -$2,121,282 | +$4,782,425 | T, ABBV, CVS, BMY, IP | 13F-HR | 21 Oct 2014, 11:29 |
| Q2 2014 | 76 | $120,860,000 | +$7,934,468 | -$3,775,430 | +$4,159,038 | T, CVS, ABBV, PBA, BMY | 13F-HR | 24 Jul 2014, 09:17 |
| Q1 2014 | 68 | $111,686,000 | +$2,326,266 | -$9,380,625 | -$7,054,359 | T, CVS, ABBV, BMY, PBA | 13F-HR | 24 Apr 2014, 12:13 |
| Q4 2013 | 73 | $117,500,000 | $0 | $0 | $0 | T, BMY, CVS, ABBV, PBA | 13F-HR | 16 Jan 2014, 15:14 |